2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| No statute on record | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ABBAS, SYED JARAR | 1 | — | — |
| STONEBRAKER, ALYSSA RAE | 1 | 54.4% | +52.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18016279 | ANTI-CLDN-18.2 ANTIBODY AND USE THEREOF | STONEBRAKER, ALYSSA RAE | 26d |
| Art Unit | Apps |
|---|---|
| 1674 | 1 |
| 1642 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18297983 | Compositions and Methods for Treating Solid Tumors with Anti-BTLA as Mono or Combination Therapy | ABBAS, SYED JARAR | 1674 | Other | Non-Final OA | 15d | Pending | Apr 10, 2023 |
| 18016279 | ANTI-CLDN-18.2 ANTIBODY AND USE THEREOF | STONEBRAKER, ALYSSA RAE | 1642 | Other | Non-Final OA | 26d | Pending | Jan 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial